Lung cancer screening promises to find cancer early and treat it before it progresses. But a year on, issues have emerged.
Articles on Lung cancer screening
Displaying all articles
Medical imaging contains a veritable wealth of information that is often missed. One way this can change is for patients to ask their doctors what more they can learn from their image results.
The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.
The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s what’s involved.
Stigma, fear and cost prevent many patients from getting screened for lung cancer. This can prove deadly for the most vulnerable.
The success of anti-smoking campaigns has come with growing stigma around lung cancer. Over one quarter of Australians admit they have less sympathy for lung cancer sufferers.
While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. New screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
PODCAST: The third part of a series from The Anthill podcast on how personalised medicine may become in the future.
Cancer mortality has dropped in the US, due largely to lower smoking rates, as well as early detection and better treatments. These advances often do not extend to people in developing nations.
Top contributors
-
Associate Director of Community Outreach in Thoracic Oncology, University of Miami
-
Principal Research Fellow in the Centre for Regional Economic and Social Research (CRESR) and Associate Fellow of the Advanced Wellbeing Research Centre (AWRC), Sheffield Hallam University
-
Postdoctoral Research Fellow, University of Sydney
-
ARC DECRA Senior Research Fellow, Sydney Centre for Healthy Societies, University of Sydney
-
Chief of Hematology/Oncology, Medical Director of the Cancer Center, and Eleanor Eustis Farrington Chair in Cancer Research, UMass Chan Medical School
-
Head of Personalised Medicine and Health, University of Leeds
-
Senior Lecturer Psychology, University of Westminster
-
Professor of Clinical Pharmaceutics, University of Lancashire
-
Assistant Professor of Pulmonary Sciences and Critical Care, University of Colorado Anschutz
-
Researcher, Department of Medical Oncology, Royal North Shore Hospital,, University of Sydney
-
Professor of Sociology & Director, Sydney Centre for Healthy Societies, University of Sydney
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
NHMRC Emerging Leader Research Fellow, School of Public Health, University of Sydney
-
Professor of General Practice, Bond University